Methocarbamol
- Product NDC
- 10135-664
- 11-digit product format
- 101350664
- Labeler code
- 10135
- Product ID
- 10135-664_d258986c-63ef-465b-e053-2995a90a8005
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methocarbamol
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA208507
- Marketing category
- ANDA
- Marketing start
- 2018-10-01
- Marketing end
- 0000-00-00
- Substance
- METHOCARBAMOL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-664-01 | Methocarbamol | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 4 |
| 10135-664-05 | Methocarbamol | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-664 | METHOCARBAMOL TABLET, FILM COATED [MARLEX PHARMACEUTICALS INC] | 4 | Legacy NDC, 2 package rows | 20211205_01baa84f-453e-4954-bdf1-276ad7d484a1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-664-01 | 10135066401 | 100 TABLET, FILM COATED in 1 BOTTLE (10135-664-01) | 2018-10-01 | 0000-00-00 | No | No | Current |
| 10135-664-05 | 10135066405 | 500 TABLET, FILM COATED in 1 BOTTLE (10135-664-05) | 2018-10-01 | 0000-00-00 | No | No | Current |
| 10135-664-50 | 10135066450 | 500 TABLET, FILM COATED in 1 BOTTLE (10135-664-50) | 2018-10-01 | 0000-00-00 | No | No | Current |